BofA raised the firm’s price target on HealthEquity to $93 from $85 and keeps a Buy rating on the shares ahead of the company hosting its first investor day since 2019 next week. The firm doesn’t think investors are expecting material news from next week’s event, which is noteworthy if there is a large announcement and it raised its price target due to peer multiple expansion ahead of next week’s event.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on HQY:
- HealthEquity Recognized by Glassdoor as a Top U.S. Workplace for 2024
- Wells says key metrics tracking ahead as HealthEquity provides sales outlook
- HealthEquity Announces Year-End HSA Sales Outlook; Presentation at J.P. Morgan Healthcare Conference; Investor Day
- HealthEquity announces HSA sales outlook
- Barclays starts healthcare technology, distribution with Neutral view
Questions or Comments about the article? Write to editor@tipranks.com